Pharmacological treatment or endoscopic sclerotherapy as primary intervention for variceal bleeding in cirrhotic patients?;Farmakologisk behandling eller endoskopisk skleroterapi som primær intervention ved variceblødning hos cirrosepatienter?

Ugeskrift for Laeger

Volumn 165, Issue 11, 2003, Pages 1127-1130

  Grønbœk, Henning ^a   Dahlerup, Jens F ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN; VASOPRESSIN; HEMOSTATIC AGENT; VASOPRESSIN DERIVATIVE;

BLOOD TRANSFUSION; CLINICAL TRIAL; ENDOSCOPY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; MORTALITY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; SCLEROTHERAPY; SHORT SURVEY; ARTICLE; ESOPHAGUS VARICES; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; META ANALYSIS; METHODOLOGY;

ESOPHAGEAL AND GASTRIC VARICES; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HEMOSTATICS; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; META-ANALYSIS; SCLEROTHERAPY; SOMATOSTATIN; VASOPRESSINS;

EID: 0347763429     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. De Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390-4.
2. Westaby D. Emergency and elective endoscopic therapy for variceal haemorrhage. Baillieres Clin Gastroenterol 1992;6:465-80.
3. Corley DA, Cello JP, Adkisson W. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001;120:946-54.
4. Gotzsche PC. Somatostatin analogues for acute bleeding oesophageal varices (Cochrane Review). I: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
5. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage (Cochrane Review). I: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
6. D'Amico G, Pietrosi G, Tarantino I et al. Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients (Cochrane Review). I: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
7. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505.
8. Banares R, Albillos A, Rincón D et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a metaanalysis. Hepatology 2002;35:609-15.
9. Levacher S, Letoumelin P, Pateron D et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865-8.
10. Bendtsen F, Becker PU. Behandling af esophagusvaricer. Ugeskr Læger 2001;163:1552-6.
11. Bernard B, Grange JD, Khac EN et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999;29:1655-61.
12. Grønbæk H, Astrup LB, Nielsen DT et al. Transjugulær intrahepatisk portosystemisk shunt (TIPS) til behandling af komplikationer ved portal hypertension hos patienter med levercirrose. Ugeskr Læger 2003;165: 439-42.